Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema

NCT01492400 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

363

Enrollment

INDUSTRY

Sponsor class

Conditions

Macular Edema

Interventions

DRUG: dexamethasone Intravitreal Implant
DRUG: ranibizumab

Sponsor

Allergan